Collaborations & Alliances

CRISPR & ProBioGen Announce Research Collaboration

Focused on the development of novel in vivo delivery modalities for CRISPR/Cas9 leveraging ProBioGen’s existing technology and expertise

01.22.19

Breaking News | Collaborations & Alliances | Industry News

Alliance Contract Pharma Supports Eye Drug Approval

FDA green lights first twice-daily, nano-milled ocular corticosteroid

01.22.19

Bio News | Collaborations & Alliances | Industry News

BioMed X, Boehringer Partner for Psychiatric Diseases

Companies originally started collaborating in 2014; new project will focus on new concepts & approaches for early intervention of psychiatric diseases

01.17.19

Alkermes Announces Grant Recipients

The 1st Annual Alkermes Pathways Research Awards (SM) Program granted approximately $400,000 for research projects focused on substance use disorders

01.16.19

Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News

Biomunex & Sanofi Enter Licensing Agreement

Sanofi will have access to Biomunex' proprietary technology to generate and optimize bi- and multi-specific antibody therapeutics

01.15.19

Breaking News | Collaborations & Alliances | Drug Development

Lonza, Takeda Alliance Reaches Milestone

Takeda’s ALUNBRIG granted marketing authorization for ALK+ non-small cell lung cancer

01.11.19

Bio News | Collaborations & Alliances | Industry News | Methods Development | R&D

GE, Vanderbilt Enter Five Year Cancer Collaboration

To enable safer and more precise cancer immunotherapies

01.10.19

Johnson Matthey, Immunomedics Partner for Cancer

Strategic manufacturing partnership is for the large-scale production of the drug-linker used in Immunomedics’ lead antibody-drug conjugate

01.10.19

Bio News | Collaborations & Alliances | Drug Development | Industry News | R&D

Selexis & Agenus Expand CLAs

Agenus will leverage Selexis’ modular SUREtechnology Platform for the rapid, stable, and cost-effective production of its therapeutic proteins

01.10.19

Clinigen Extends Agreement with Accord Health

The agreement now covers Accord’s European Solid Dose Products, including those in the central nervous system, autoimmune, diabetes and anti-viral therapy areas

01.10.19

Analytical Services | Bio News | Collaborations & Alliances | Industry News | R&D

Visikol to Launch OpenLiver Initiative

Suite of open source liver 3D cell culture models will be unveiled at the SLAS conference

01.10.19

Bio News | cGMP Manufacture | Collaborations & Alliances | Industry News

Pii to Manufacture FDA Approved Injection Drug Product

Academic Pharmaceuticals received FDA approval of Bretylium Tosylate Injection USP, 500 mg/10 mL (50 mg/mL) Single-Dose Vials on December 21, 2018

01.09.19

Bio News | Collaborations & Alliances | Drug Development | Industry News

Gilead, Yuhan Enter Licensing Agreement

To co-develop novel therapeutic candidates for the treatment of patients with advanced fibrosis due to nonalcoholic steatohepatitis

01.08.19

Bio News | Collaborations & Alliances | Industry News

Evotec, Celgene Collaboration Reaches Milestone

Resulting in Celgene designating a program and triggering a payment of $ 14M to Evotec

01.08.19

Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News

CANbridge, WuXi Biologics Expand Partnership

Their rare disease partnership will enable CANbridge to discover, develop and commercialize four additional drug candidates

01.08.19

Breaking News | Collaborations & Alliances | Drug Development

Immutep, CYTLIMIC Enter Clinical Trial Collaboration

Immutep to provide technical support services and supply efti to CYTLIMIC for the manufacture of CYT001 for clinical development and commercialization

01.07.19

Breaking News | Collaborations & Alliances | Drug Development | Industry News